Xenetic Biosciences (XBIO) Change in Cash (2011 - 2026)
Xenetic Biosciences' (XBIO) quarterly Change in Cash came in at -$536377.0 in Q1 2026, up 46.46% YoY from -$366218.7 in Q1 2025, and down 114.26% on a QoQ basis from $3.8 million in Q4 2025.
Xenetic Biosciences (XBIO) Change in Cash (2011 - 2026) Analysis & Trends
Xenetic Biosciences (XBIO) has 16 years of Change in Cash data on file, last reported at -$536377.0 in Q1 2026.
- Quarterly Change in Cash rose 46.46% year-over-year to -$536377.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 182.09% YoY) and the FY2025 annual result came in at $1.7 million, up 160.98% from the prior year.
- Change in Cash slipped to -$536377.0 in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $3.8 million in Q4 2025 to a low of -$2.1 million in Q1 2022.
- A 5-year average of -$640986.8 and a median of -$793027.0 in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 110.36% — and 2025, when it soared 658.17%.
- Tracing XBIO's Change in Cash over 5 years: stood at -$750907.0 in 2022, then decreased by 5.61% to -$793027.0 in 2023, then increased by 15.01% to -$673992.0 in 2024, then soared by 658.17% to $3.8 million in 2025, then plunged by 114.26% to -$536377.0 in 2026.
- The last three Change in Cash figures came in at -$536377.0 (Q1 2026), $3.8 million (Q4 2025), and -$658247.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | -875,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -875,489.00 |
| Mar 31, 2026 | -536,377.00 |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | -658,247.00 |
| Jun 30, 2025 | -383,830.00 |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | -673,992.00 |
| Sep 30, 2024 | -459,037.00 |
| Jun 30, 2024 | -525,104.00 |
| Mar 31, 2024 | -1.16 Mn |
| Dec 31, 2023 | -793,027.00 |
| Sep 30, 2023 | -949,634.00 |
| Jun 30, 2023 | -1.27 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -750,907.00 |
| Sep 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -1.23 Mn |
| Mar 31, 2022 | -2.09 Mn |
| Dec 31, 2021 | -1.46 Mn |
| Sep 30, 2021 | 10.42 Mn |